Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
Chinese Journal of Immunology ; (12): 905-909, 2017.
Article in Chinese | WPRIM | ID: wpr-617436

ABSTRACT

Objective:To observe immunological indexes,the quantity of cytokine expression and clinical curative effect of umbilical cord mesenchymal stem cells between before and after the treatment of systemic lupus erythematosus patients.Methods:Selected 10 cases of SLE,on the basis of glucocorticoid and immune inhibitor treatment,intravenous injection UC-MSC of cultivating proliferation within 6 generations.Before and after treatment of UC-MSC testing the relative quantity of cytokine of CTLA-4,IL-15,IL-2,CD86,IL-17c,Foxp3,TGF-β2 which were related of immunopathogenesis of SLE.Before and after treatment to determined SLE disease activity index (SLEDAI) score and detection of blood in the urine routine,liver and kidney function,24 hours urinary protein quantitative,immunoglobulin and complement levels.Results:After treatment the relative expression value of IL-15 and IL-2 was decreased,CTLA-4 was risen.There had no significant difference with the relative expression value of CD86,IL-17c,Foxp3,TGF-β2 in before and after treatment of UC-MSC.After treatment serum complement C3 and C4 level,serum albumin,were risen.24 hour proteinuria and SLEDAI were decreased.There was no serious adverse reaction occurred,no complications related to transplantation in 10 cases.Conclusion:UC-MSC can regulate the expression of cytokines of participate in the immune response in the patients with SLE.Treatment of SLE by UC-MSC can elevate serum albumin and C3 and C4 level,reduce the 24 hours urinary protein quantity,relife kidney damage,improve clinical symptoms;UC-MSC transplantation in patients with SLE have good security;UC-MSC transplantation may be a feasible method for the treatment of SLE.

2.
Chinese Mental Health Journal ; (12)2002.
Article in Chinese | WPRIM | ID: wpr-587075

ABSTRACT

Objective: To compare the efficacy of paroxetine and amitriptyline in the treatment of primary fibromyalgia syndrome.Methods:46 out- and in-patients with primary fibromyalgia syndrome were randomized to two groups and treated respectively with amitriptyline 25mg~50mg per day and paroxetine 10mg~20mg per day. The Visual analogue scales(VAS) was used to evaluate the efficacy and adverse effects were recorded at baseline, month 1 and month 3.Results:In both groups pain was alleviated with statistical significance after 1 month of treatment. However the efficacy of amitriptyline and paroxetine was not statistically significant at different time points. The occurrence of adverse effects in paroxetine group was less than in amitriptyline group and the difference was statistically significant, especially dry mouth and palpitation.Conclusion:Paroxetine is as effective as amitriptyline in the treatment of primary fibromyalgia syndrome but with a better safety profile.

3.
Journal of Kunming Medical University ; (12)1988.
Article in Chinese | WPRIM | ID: wpr-673120

ABSTRACT

In this paper,the candida carrier rate of 1996 healthy infants and juveniles of the Han,Dai and Zang nationalities was reported.The specimens were taken from the tongue,cheek mucosa,stool,urine,finger web and vagina.The carrier rate of C.albicans in the mouth was significantly higher than that in the other regions. C.albicans at the tongue of the Han,Dai and Zang people was 4.5%,5.3%, 1.07% respectively.Therefore,C.albicans' residence in the mouth was probably an important source of the internal infection of candidiasis.Of the 1996 healthy individuals none had C.albicans isolated from the urine.The carrier rate of C. albicans isolated from the vagina was only 0.15% in the Han and zero in the Dai and Zang.The carrier rate of candida was least in the newborn.Our data also suggested that the carrier rate of candida at the tongue was much higher than that at the cheek mucosa.Regard must be paid when isolating fungi from the mouth.

SELECTION OF CITATIONS
SEARCH DETAIL